BriaCell Therapeutics Corp. Quarterly Liabilities and Equity in USD from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
BriaCell Therapeutics Corp. quarterly Liabilities and Equity history and growth rate from Q2 2021 to Q1 2024.
  • BriaCell Therapeutics Corp. Liabilities and Equity for the quarter ending April 30, 2024 was $6.2M, a 79.1% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $6.2M -$23.5M -79.1% Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $12.2M -$21.9M -64.2% Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $18.6M -$19.8M -51.6% Oct 31, 2023 10-Q 2023-12-14
Q2 2023 $27.2M -$15.4M -36.2% Jul 31, 2023 10-Q 2024-06-14
Q1 2023 $29.7M Apr 30, 2023 10-Q 2023-06-14
Q4 2022 $34.2M Jan 31, 2023 10-Q 2023-03-16
Q3 2022 $38.5M Oct 31, 2022 10-Q 2022-12-14
Q2 2022 $42.6M -$15.5M -26.6% Jul 31, 2022 10-K 2023-10-25
Q2 2021 $58M Jul 31, 2021 10-K 2022-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.